annual SGA:
$23.78M+$4.82M(+25.43%)Summary
- As of today (July 11, 2025), ELVN annual SGA is $23.78 million, with the most recent change of +$4.82 million (+25.43%) on December 31, 2024.
- During the last 3 years, ELVN annual SGA has risen by +$19.49 million (+454.48%).
- ELVN annual SGA is now at all-time high.
Performance
ELVN SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$6.80M+$626.00K(+10.14%)Summary
- As of today (July 11, 2025), ELVN quarterly SGA is $6.80 million, with the most recent change of +$626.00 thousand (+10.14%) on March 31, 2025.
- Over the past year, ELVN quarterly SGA has increased by +$781.00 thousand (+12.98%).
- ELVN quarterly SGA is now at all-time high.
Performance
ELVN quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$932.92M-$94.83M(-11.32%)Summary
- As of today (July 11, 2025), ELVN TTM SGA is -$932.92 million, with the most recent change of -$94.83 million (-11.32%) on March 31, 2025.
- Over the past year, ELVN TTM SGA has dropped by -$953.35 million (-4665.51%).
- ELVN TTM SGA is now -1963.88% below its all-time high of -$45.20 million.
Performance
ELVN TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ELVN Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.4% | +13.0% | -4665.5% |
| 3 y3 years | +454.5% | +319.9% | -10000.0% |
| 5 y5 years | +2105.6% | +344.0% | -10000.0% |
ELVN Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +454.5% | at high | +530.0% | -687.2% | at low |
| 5 y | 5-year | at high | +2105.6% | at high | +530.0% | -1963.9% | at low |
| alltime | all time | at high | +2105.6% | at high | +530.0% | -1963.9% | at low |
ELVN Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $6.80M(+10.1%) | $24.56M(+3.3%) |
| Dec 2024 | $23.78M(+25.4%) | $6.17M(+6.2%) | $23.78M(+6.0%) |
| Sep 2024 | - | $5.81M(+0.6%) | $22.43M(+5.5%) |
| Jun 2024 | - | $5.78M(-4.0%) | $21.26M(+4.0%) |
| Mar 2024 | - | $6.02M(+24.7%) | $20.43M(+7.8%) |
| Dec 2023 | $18.95M | $4.82M(+3.9%) | $18.95M(+17.8%) |
| Sep 2023 | - | $4.64M(-6.2%) | $16.10M(+10.6%) |
| Jun 2023 | - | $4.95M(+9.1%) | $14.56M(+36.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $4.54M(+130.8%) | $10.69M(+37.6%) |
| Dec 2022 | $7.77M(+81.2%) | $1.97M(-36.7%) | $7.77M(+5.9%) |
| Sep 2022 | - | $3.10M(+187.8%) | $7.33M(+73.4%) |
| Jun 2022 | - | $1.08M(-33.4%) | $4.23M(+34.3%) |
| Mar 2022 | - | $1.62M(+5.7%) | $3.15M(+105.7%) |
| Dec 2021 | $4.29M(+297.8%) | - | - |
| Dec 2021 | - | $1.53M | $1.53M |
| Dec 2020 | $1.08M | - | - |
FAQ
- What is Enliven Therapeutics, Inc. annual SGA?
- What is the all time high annual SGA for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual SGA year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly SGA?
- What is the all time high quarterly SGA for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly SGA year-on-year change?
- What is Enliven Therapeutics, Inc. TTM SGA?
- What is the all time high TTM SGA for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. TTM SGA year-on-year change?
What is Enliven Therapeutics, Inc. annual SGA?
The current annual SGA of ELVN is $23.78M
What is the all time high annual SGA for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual SGA is $23.78M
What is Enliven Therapeutics, Inc. annual SGA year-on-year change?
Over the past year, ELVN annual SGA has changed by +$4.82M (+25.43%)
What is Enliven Therapeutics, Inc. quarterly SGA?
The current quarterly SGA of ELVN is $6.80M
What is the all time high quarterly SGA for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly SGA is $6.80M
What is Enliven Therapeutics, Inc. quarterly SGA year-on-year change?
Over the past year, ELVN quarterly SGA has changed by +$781.00K (+12.98%)
What is Enliven Therapeutics, Inc. TTM SGA?
The current TTM SGA of ELVN is -$932.92M
What is the all time high TTM SGA for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high TTM SGA is -$45.20M
What is Enliven Therapeutics, Inc. TTM SGA year-on-year change?
Over the past year, ELVN TTM SGA has changed by -$953.35M (-4665.51%)